4 resistance determining regions (QRDRs) at codon 83 (serine to leucine) and codon 87 (aspartic 79 acid to glycine/asparagine) in gyrA, and at codon 80 (serine to isoleucine) in parC 11, 12 . From 80 2010 onwards, cipR S. sonnei emerged as a major global health concern, becoming widely 81 distributed through international travel and ensuing domestic transmission [13] [14] [15] . To date, cipR S. 82 sonnei has been reported in children across Asia 16,17 , as well as homeless individuals and men-83 who-have-sex-with-men (MSM) in Canada, the US, Taiwan, and the UK 14,18-20 . Of further 84 concern is the observation that cipR S. sonnei have the ability to acquire resistance to second-line 85 alternative drugs such as ceftriaxone 21 , which further limits alternative treatment options. 86 87 Our previous work demonstrated that all cipR S. sonnei globally were clonal and emerged once 88 from a single lineage that likely arose in South Asia 22 . Here, we describe the expansion of a 89 single lineage III clade of cipR S. sonnei by providing phylo-temporal insights into its extant 90 clonal dynamics using clinical samples obtained from children admitted to three paediatric 91 facilities in Ho Chi Minh City (HCMC) between 2014 and 2016. We observe replacement of the 92 resident ciprofloxacin susceptible (cipS) clone by the novel cipR lineage, as well as the 93 concurrent and independent acquisition of a diverse range of resistance plasmids, which lead to 94 MDR and XDR phenotypes. Through a detailed analysis of the plasmid content from commensal 95 E. coli and S. sonnei isolated from a single patient and a series of conjugation experiments, we 96 provide compelling evidence that ciprofloxacin exposure influences the de novo acquisition of 97 MDR and XDR plasmids. Our data suggest that following the current international guidelines for 98
Shigella therapy may lead to these cipR variants becoming resistant to alternative antimicrobials. 99 100 Methods 101
Study Design 102
The S. sonnei used in this study were isolated during a 2-year observational study conducted at 103 three tertiary hospitals (Children's Hospital 1, Children's Hospital 2, and the Hospital for 104 5 Tropical Diseases) in HCMC, Vietnam, between May 2014 and April 2016, as previously 105 described ( Supplementary Table 1) 23 . In brief, children aged <16 years admitted to one of the 106 three study hospitals with diarrhea (defined as ≥ 3 passages of loose stools within 24 hours) and 107 >1 loose stool containing blood and/or mucus were recruited. A fecal sample was collected and 108 processed within 24 hours after enrolment. All hospitalized patients received standard of care 109 treatment at each of the study sites. Treatment and clinical outcomes (e.g. patient recovery status 110 (three days after enrolment) and duration of hospital stay) were recorded by clinical staff at the 111 study sites. For the phylogenetic analyses, we additionally included two cipR S. sonnei as acquired non-susceptibility to at least one agent in three or more antimicrobial categories; 136 XDR was defined as non-susceptibility to at least one agent in all but two or fewer antimicrobial 137 categories (i.e. bacterial isolates remain susceptible to only one or two categories) 24 . Detection of 138
Extended Spectrum Beta Lactamase (ESBL) activity was performed for all isolates that were 139 resistant to ceftriaxone using the combination disc method (cefotaxime, 30µg; ceftazidime, 30µg; 140 with and without clavulanic acid, 10µg). ESBL-producing organisms were defined as those 141 exhibiting a >5mm increase in the size of the zone of inhibition for the beta-lactamase inhibitor 142 combinations in comparison to a third-generation cephalosporin without the beta-lactamase 143 inhibitor. 144
145

Isolation of commensal bacteria 146
For the purposes of this study we defined commensal organisms as organisms isolated from the 147 stool samples of children thought not to be associated with the observed episode of diarrheal 148 disease. In children with and without Shigella infections (i.e. symptomatic and asymptomatic 149 children), non-Shigella organisms grown on MC plates were considered to be commensals. 150
Colony sweeps from MC agar from Shigella-infected children were serially diluted and plated 151 onto the MC agar without antimicrobial selection. All single colonies with a different color and 152 morphology from that of S. sonnei were harvested, identified and homogenized in 20% glycerol. 153
Subsequently, DNA was extracted from these commensal bacteria by boiling and was then 154 subjected to qualitative real-time PCR with primers and probes specific for Shigella to detect if 155 these samples were contaminated with Shigella 25 . To determine the AMR gene and plasmid 156 7 diversity in human commensal bacteria, we also included a subset of commensal bacteria 157 recovered from the rectal swabs of 18 healthy children enrolled in a longitudinal cohort study 158 with active surveillance for diarrheal disease in HCMC between 2014 and 2016 26 macrolides, and aminoglycosides, consequently creating XDR variants. In 2014, the proportion of 311 13 co-resistance against ceftriaxone, ceftriaxone-azithromycin, and ceftriaxone-azithromycin-312 gentamicin was 59% (10/17), 11.8% (2/17), and 5.9% (1/17), respectively. These respective 313 proportions increased to 87% (13/15), 47% (7/15), and 40% (6/15) in 2016. 314
315
Our analyses show that co-resistance in cipR S. sonnei was generated by sustained and 316 independent acquisitions of ESBL-encoding plasmids (plasmid acquisition events, herein referred 317 to as PAs, Figure 1 ). These plasmids carried differing variants of the bla CTX-M gene and/or mphA. 318
Notably, this phenomenon was not characterized by selection of the same plasmid/clone 319 combination; we identified at least thirteen independent acquisitions of ESBL-encoding plasmids 320 across the phylogenetic tree ( Figure 1 (Figure 1 ). The inferred time from the most recent common ancestor to the youngest 338 isolate in each resistant clone was estimated to be at least three years. We also detected the loss of 339 IncB/O plasmids on two occasions, suggesting a potential lack of IncB/O plasmid stability in 340 comparison to the IncI plasmids. 341
342
The structure of XDR plasmids in ciprofloxacin-resistant Shigella sonnei 343
We assessed the plasmid content of all S. sonnei isolates by comparing the banding patterns of 344 crude undigested plasmid extracts. Our data showed that all cipR isolates exhibited a distinct 345 plasmid profile from that of the resident Vietnamese S. sonnei isolates ( Supplementary Figure 2) . 346
Additionally, all cipR S. sonnei isolates carrying bla CTX-M and/or mphA consistently harbored a 347 large (90 kb to 110 kb) plasmid. An analysis of the EcoRI digestion profiles of these ESBL-348 encoding plasmids showed two major independent clusters, consistent with IncI and IncB/O 349 plasmid backbones (Figure 2A) . Notably, the genetic structure within each plasmid group 350 appeared to be highly conserved, with the IncI and IncB/O plasmids sharing ~70% and ~60% 351 similarity in their respective restriction patterns. Given the diversity of the AMR plasmids observed in cipR S. sonnei, their similarity to E. coli 396 plasmids, and the fact that humans are the only natural reservoir for S. sonnei, we speculated that 397 these plasmids had been transferred from commensal E. coli into S. sonnei during infection. 398
Consequently, we performed additional characterization of AMR genes and plasmid diversity in 399 commensal Enterobacteriaceae isolated from the same fecal samples that contained S. sonnei and 400 from rectal swabs taken from healthy children. Metagenomic sequencing of these mixed bacterial 401 populations (lacking Shigella) from MC plates indicated that E. coli was the most commonly 402 isolated commensal Enterobacteriaceae (47/48 pooled colonies), followed by Klebsiella 403 pneumoniae (7/48 pooled colonies) and Enterobacter cloacae (1/48 pooled colonies). 404
405
The resulting sequence data identified a substantial quantity of AMR genes and plasmid 406 backbones in the commensal Enterobacteriaceae ( Supplementary Figure 3 and Figure 3A) . We 407 observed a particularly high prevalence of CipR commensal Enterobacteriaceae; this has been 408 observed previously and is considered to be associated with sustained antimicrobial exposure and 409 competition in the gastrointestinal tract 48 . Furthermore, a number of different AMR determinants 410 were found to be present in both the commensal bacteria and the cipR S. sonnei. For example, 411 bla CTX-M , mphA, aac3-IIa, and ermB were found to be present in cipR S. sonnei and 92% (44/48), 412 75% (36/48), 52% (25/48), and 38% (18/48) of pooled commensal Enterobacteriaceae, 413 respectively ( Figure 3A) . IncF (IncFII, IncFIA, IncFIB, and IncFIC) plasmids were found to be 414 the most prevalent replicon types in the commensal Enterobacteriaceae. However, we additionally 415 sequence and produced a plasmid with 100% coverage (mean mapping coverage: 15, standard 432 deviation: 7). The assembled plasmid contigs from cipR S. sonnei 01-0123 shared 100% sequence 433 identity ( Figure 3B) . These data and the location of this organism on the phylogenetic tree 434 suggest that this resistance plasmid was potentially transferred in vivo between commensal E. coli 435 and cipR S. sonnei 01-0123 in the gut of the child. 436 437
Ciprofloxacin increases the conjugation frequency of ESBL plasmids between commensal 438
Escherichia coli and ciprofloxacin-resistant Shigella sonnei 439
Our data illustrates that commensal E. coli are an important reservoir of AMR genes and may be 440 transferred to S. sonnei in vivo. Furthermore, the high diversity of AMR plasmids observed here 441 18 in a single S. sonnei lineage is atypical and has not been previously observed in a geographically 442 restricted clonal expansion. The reason for this observation is unclear but we suspect is associated 443 with the combination of a permissive circulating clone, exposure to fluoroquinolones, and a wide 444 variety of AMR plasmids in the resident commensal population. We also observed that the 445 majority of S. sonnei infected children (85%, 67/79) were treated with ciprofloxacin, an 446 antimicrobial agent that can trigger the SOS response and promote horizontal gene transfer in 447 bacteria [49] [50] [51] [52] [53] [54] . Consequently, we hypothesized that this array of resistance plasmids was associated 448 with a cipR phenotype and that ciprofloxacin treatment may facilitate plasmid transfer in vivo. Although the cipR S. sonnei sublineage Central Asia III has spread internationally, the 500 development of XDR within this lineage has not been reported previously. S. sonnei are highly 501 efficient at spreading internationally; therefore, the identification and pervasiveness of AMR in 502 these organisms means that future investigations should monitor their international circulation to 503 provide early warning for public health authorities and healthcare providers. More specifically, 504 the emergence and expansion of cipR XDR S. sonnei clones associated with ISecp1-bla CTX-M-55 505 raises a major concern regarding the epidemic potential of this novel CTX-M ESBL variant in S. 506 sonnei 66-68 . A significant burden of shigellosis, high prevalence of AMR among Gram-negative 507 commensal bacteria, and the purchasing of antimicrobials in the community may be factors 508 contributing to the emergence and maintenance of XDR S. sonnei in Vietnam. 509
510
We describe multiple different plasmid structures in the cipR S. sonnei population, distinguishing 511 their dynamics from those of the resident S. sonnei population, which underwent a clonal 512 expansion characterized by a single plasmid structure 47 . In most cases when a mphA/bla CTX-M 513 plasmid was acquired, the plasmids appeared not to become established in the population. This 514 observation suggests that these structures could have a sustained fitness disadvantage in the 515 absence of antimicrobial pressure. Conversely, the successful maintenance of four independent 516 XDR S. sonnei clones warrants further investigation into their potential fitness, plasmid stability, 517 
